Govt Job for M.Pharm to work in ICMR funded project

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to create and put into action such ideas, methods, techniques and information”.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by ICMR, under the supervision of Prof. Rajeev Taliyan, Department of Pharmacy, BITS-Pilani, Pilani Campus, Rajasthan

Title of the project : Exploring the mechanism(s) of gut microbiota link to Parkinson Disease pathology and its reversal based on fibroblast growth factor 21 gene delivery through lentivirus system

Fellowship amount : 31000/- per month

Eligibility requirements : M.Pharm / M.S. (Pharm.) in Pharmacology / Pharmaceutics, Pharmaceutical technology and Pharm. Analysis with GATE / GPAT / CSIR-NET / DST-INSPIRE or equivalent examination.

Duration of the project : 03 Years

Interested candidates with the above mentioned qualification can send the applications on a plain paper giving detailed information about the educational qualifications, research experience and published research papers if any via email by 18th January 2021 to the Principal Investigator, Prof .Rajeev Taliyan [Email: rajeev.taliyan@pilani.bits-pilani.ac.in].

Please note that only qualified and suitable candidates will be called for online interview to be held by end of 3rd week of January 2021 and no TA/DA will be paid for the interview. Selected candidate may be permitted to register for Ph.D programme of BITS, Pilani, subject to the fulfillment of the requirements.

PI : Dr. Rajeev Taliyan (Associate Professor)

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states